857119P

06:0 Lyso PA

Avanti Research^™ - A Croda Brand

• Sinônimo(s): 1-hexanoyl-sn-glycero-3-phosphate (ammonium salt); PA(6:0/0:0)
• Fórmula empírica (Notação de Hill): C₉H₂₂NO₇P
• Número CAS: 384835-45-4
• Peso molecular: 287.25
• Código UNSPSC: 51191904
• NACRES: NA.25

Propriedades

• descrição: 1-hexanoyl-2-hydroxy-sn-glycero-3-phosphate (ammonium salt)
• Ensaio: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
• forma: powder
• embalagem: pkg of 1 × 25 mg (857119P-25mg)
• fabricante/nome comercial: Avanti Research^™ - A Croda Brand
• tipo de lipídio: cardiolipins; phospholipids
• Condições de expedição: dry ice
• temperatura de armazenamento: −20°C
• cadeia de caracteres SMILES: O[C@](COP([O-])(O)=O)([H])COC(CCCCC)=O.[NH4+]

Descrição

Descrição geral

Lysophosphatidic acid (LPA) belongs to a class of phospholipids, that has a glycerol backbone attached by a phosphate group, an aliphatic chain and a hydroxyl group. It has a phosphate group attached to sn-3 position, an aliphatic chain attached to sn-1 or sn-2 position and the hydroxyl group attached to the remaining sn-1 or sn-2 position. 06:0 Lyso PA/HHGP, belongs to the LPA (lysophosphatidic acid) family. It is a negatively charged single chain lipid.

Lysophosphatidic acid (LPA) has a free hydroxyl and phosphate moiety. It is hydrophilic and is not associated with the membrane. It is the major constituent of serum.

Aplicação

06:0 Lyso PA (LPA) has been used in the structure-activity relationship (SAR) analysis with G-protein receptor GPR92. It has also been used in lipid assay in the treatment of serum-starved primary mouse embryonic fibroblast cells.

06:0 Lyso PA has been used to study the role of lipid binding to MxiM protein in co‐crystallization experiments.

Ações bioquímicas/fisiológicas

Lysophosphatidic acid (LPA) is the precursor for the synthesis of phospholipids in eukaryotes and prokaryotes. It acts as an intercellular signaling molecule. Activated platelets produce LPA. It plays a major role in tissue healing and wound regeneration. LPA binds to G-protein coupled receptors. It possesses mitogenic properties. LPA inhibits differentiation of neuroblastoma and myoblast, aids in neurotransmitter release and smooth muscle contraction. It is a potential biomarker for ovarian and gynecological cancers. It is implicated in the initiation of neuropathic pain.

Lysophosphatidic acid (LPA) participates in several biological functions. LPA stimulates platelet aggregation, chemotaxis, cytoskeleton rearrangement, Ca²⁺ mobilization and cell proliferation. 06:0 Lyso PA/HHGP possesses a micromolar binding affinity for global regulator of LEE (locus of enterocyte effacement) repressor (GrlR) and for β-lactoglobulin.

Embalagem

5 mL Amber Glass Screw Cap Vial (857119P-25mg)

Informações legais

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids